Carina Namih is CEO and co-founder of HelixNano, a health technology company backed by Johnson and Johnson Innovation. The company lies at the rapidly emerging intersection of software and biomedicine – working to revolutionize how our bodies are monitored and treated. Carina is recognized as the BioBeat Rising Star of British Biotech and a World Economic Forum ‘Global Shaper’. She frequently shares her experience of building innovative, technology-led businesses as an advisor to start-ups, to investors and as a speaker.